Shanghai MicroPort Endovascular MedTech Co., Ltd.

SHSE:688016 Voorraadrapport

Marktkapitalisatie: CN¥12.6b

Shanghai MicroPort Endovascular MedTech Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Qing Zhu

Algemeen directeur

CN¥3.9m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO6.3yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn3.7yrs
Gemiddelde ambtstermijn bestuur1.8yrs

Recente managementupdates

Recent updates

Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Attractive Earnings Are Not All Good News For Shareholders

Nov 06
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Attractive Earnings Are Not All Good News For Shareholders

There's No Escaping Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Muted Earnings Despite A 31% Share Price Rise

Oct 01
There's No Escaping Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Muted Earnings Despite A 31% Share Price Rise

Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts

Aug 29
Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts

Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends

Aug 15
Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends

Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel

Jun 29
Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel

These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely

Apr 29
These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely

Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem

Apr 09
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem

Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

Mar 25
Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't

CEO

Qing Zhu (43 yo)

6.3yrs

Tenure

CN¥3,943,900

Compensatie

Mr. Qing Zhu is GM & Director of Shanghai MicroPort Endovascular MedTech Co., Ltd. He was Deputy General Manager of Shanghai MicroPort Endovascular MedTech Co., Ltd.


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Qing Zhu
GM & Directorno dataCN¥3.94mgeen gegevens
Chun Fang Li
Accounting Supervisor & CFO3.1yrsCN¥1.21mgeen gegevens
Genyong Qiu
Deputy GM & Secretary of the Board of Directors2.6yrsCN¥1.89mgeen gegevens
Zhenyu Yuan
Deputy GM & Core Technical Personnel5.7yrsCN¥2.13mgeen gegevens
Lantao Guo
Deputy GM & Core Technical Personnel4.3yrsCN¥1.79mgeen gegevens
Ke Chen
Senior Directorno dataCN¥1.68mgeen gegevens
Hongjie Lu
Core Technical Staffno dataCN¥488.00kgeen gegevens
Liwen Wang
Core Technical Staffno dataCN¥687.10kgeen gegevens

3.7yrs

Gemiddelde duur

44yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 688016 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Qing Zhu
GM & Director6.3yrsCN¥3.94mgeen gegevens
Jonathan H. Chen
Chairmanless than a yeargeen gegevensgeen gegevens
Linlin Cai
Employee Representative Supervisor6.3yrsgeen gegevensgeen gegevens
Xiaojie Ye
Independent Director2.7yrsgeen gegevensgeen gegevens
Min Liang
Chairman of the Supervisory Boardless than a yeargeen gegevensgeen gegevens
Chao Guo
Supervisorless than a yeargeen gegevensgeen gegevens

1.8yrs

Gemiddelde duur

40.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 688016 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw bestuur.